CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Open-market buy Director bought 116,997 shares at an average $7.51 ($878,249)
- 4 Open-market buy Director bought 26,400 shares at an average $7.16 ($189,050)
- 4 Grant or award Sr. VP, Chief Comm. Officer acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 1,349 shares (grant or award)
- 4 Grant or award Director acquired 5,398 shares (grant or award)
- 4 Grant or award Director acquired 5,398 shares (grant or award)
- 4 Grant or award Director acquired 8,097 shares (grant or award)
- 4 Open-market buy Director bought 30,000 shares at an average $7.16 ($214,874)
- 4 Open-market buy Director bought 50,000 shares at an average $7.05 ($352,261)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
Page 26 of 29 · 564 filings